Paralytic myopathy - A leading clinical presentation for primary aldosteronism in Taiwan

  • Yu Yao Huang
  • , Brend Ray Sea Hsu
  • , Jir Shiong Tsai*
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

36 Scopus citations

Abstract

Between 1982 and 1995, 43 cases of primary aldosteronism, 36 cases of adenoma, and 7 cases of hyperplasia were treated in Chang Gung Medical Center. Twenty-one of these (49%) presented with muscular paralysis as an initial symptom (categorized an the paralytic group). Seven patients in the paralytic group (33%) had extra-limb muscle involvement. Six of them presented with bulbar palsy and one patient had a peripheral-type facial palsy. The serum potassium levels in the paralytic group were significantly lower than those of the nonparalytic group (1.8 ± 0.3 vs. 2.3 ± 0.4 mmol/L, P = 0.0001). There were no significant differences in blood pressure or the serum aldosterone level between the two groups. Provocative factors such as a high carbohydrate diet, vigorous exercise, or seasonal variation did not appear to play a significant role in inducing the symptoms. Paralytic myopathy appears to be more common in Oriental people. The symptom is rarely reported among western populations. Primary aldosteronism should be considered in patients presenting with neuromuscular weakness associated with hypokalemia, regardless of the degree of hypertension.

Original languageEnglish
Pages (from-to)4038-4041
Number of pages4
JournalJournal of Clinical Endocrinology and Metabolism
Volume81
Issue number11
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Dive into the research topics of 'Paralytic myopathy - A leading clinical presentation for primary aldosteronism in Taiwan'. Together they form a unique fingerprint.

Cite this